Evidence map›Paper›PMID 27320392›Full record

ArticleMicrobes and infection2016

Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.

J Leland Booth, Elizabeth S Duggan, Vineet I Patel, Marybeth Langer, Wenxin Wu, Armin Braun, K Mark Coggeshall, Jordan P Metcalf

Open access · greenAbstract read
In one paragraph

Article in Microbes and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in cellular and infection microbiology · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Human lung ex vivo infection models.Cell and tissue research · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

J Leland BoothPulmonary and Critical Care Division of the Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: john-booth@ouhsc.edu.
Elizabeth S DugganPulmonary and Critical Care Division of the Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: elizabeth-duggan@ouhsc.edu.
Vineet I PatelPulmonary and Critical Care Division of the Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: vineet-patel@ouhsc.edu.
Marybeth LangerImmunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. Electronic address: marybeth-langer@omrf.org.
Wenxin WuPulmonary and Critical Care Division of the Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: wenxin-wu@ouhsc.edu.
Armin BraunFraunhofer Institute for Toxicology and Experimental Medicine, D-30625, Hannover, Germany. Electronic address: armin.braun@item.fraunhofer.de.
K Mark CoggeshallImmunobiology and Cancer Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA. Electronic address: mark-coggeshall@omrf.org.
Jordan P MetcalfPulmonary and Critical Care Division of the Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Electronic address: jordan-metcalf@ouhsc.edu.
University of Oklahoma Health Sciences Center · USOklahoma Medical Research Foundation · USFraunhofer Institute for Toxicology and Experimental Medicine · DE

Funding

Translation of immunologic technologies from basic research into pre-clinical nonU19AI062629 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F · 2004 to 2023
$56.2M
ZFC3H1 Regulation of Host Defense and Influenza A Virus PathogenesisP20GM103648 · NIGMS · OKLAHOMA STATE UNIVERSITY STILLWATER · PI LIU, LIN · 2013 to 2022
$22.3M
Antiviral Immunosuppression by Cigarette SmokeI01BX001937 · VA · OKLAHOMA CITY VA MEDICAL CENTER · PI METCALF, JORDAN PATRICK · 2015 to 2019
–
BLRD VA I01 BX001937NIAID NIH HHS U19 AI062629NIGMS NIH HHS P20 GM103648
6 · The paper itself

Abstract

The lung is the entry site for Bacillus anthracis in inhalation anthrax, the most deadly form of the disease. Spores escape from the alveolus to regional lymph nodes, germinate and enter the circulatory system to cause disease. The roles of carrier cells and the effects of B. anthracis toxins in this process are unclear. We used a human lung organ culture model to measure spore uptake by antigen presenting cells (APC) and alveolar epithelial cells (AEC), spore partitioning between these cells, and the effects of B. anthracis lethal toxin and protective antigen. We repeated the study in a human A549 alveolar epithelial cell model. Most spores remained unassociated with cells, but the majority of cell-associated spores were in AEC, not in APC. Spore movement was not dependent on internalization, although the location of internalized spores changed in both cell types. Spores also internalized in a non-uniform pattern. Toxins affected neither transit of the spores nor the partitioning of spores into AEC and APC. Our results support a model of spore escape from the alveolus that involves spore clustering with transient passage through intact AEC. However, subsequent transport of spores by APC from the lung to the lymph nodes may occur.

Indexed as

MovementAnthraxAntigen-Presenting CellsAntigens, BacterialBacillus anthracisBacterial ToxinsBloodCell LineEpithelial CellsHumansLungLymph NodesModels, TheoreticalOrgan Culture TechniquesSpores, Bacterialanthrax toxinAntigens, BacterialBacterial ToxinsAnthrax toxinBacillus anthracisLethal toxinLung organ cultureProtective antigen

Identifiers

PMID27320392
PMCPMC5534360
OpenAlexW2429390565

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.